Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.11)
# 516
Out of 4,915 analysts
87
Total ratings
33.72%
Success rate
24.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Maintains: Buy | $2 → $13 | $8.38 | +55.13% | 5 | Jul 10, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.1 → $1.4 | $0.49 | +188.66% | 2 | Jul 8, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $5.5 → $3 | $0.48 | +521.12% | 12 | Jun 27, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $1.30 | +207.69% | 9 | May 19, 2025 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $0.85 | +17.65% | 13 | May 15, 2025 | |
| VSTM Verastem | Maintains: Buy | $10 → $14 | $6.19 | +126.17% | 14 | May 9, 2025 | |
| DWTX Dogwood Therapeutics | Upgrades: Buy | $10 | $4.84 | +106.83% | 1 | Apr 23, 2025 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $20 | $10.58 | +89.04% | 12 | Apr 14, 2025 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $40 | $41.18 | -2.87% | 10 | Apr 1, 2025 | |
| CRVS Corvus Pharmaceuticals | Reiterates: Buy | $11 | $4.17 | +163.79% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7.5 → $9.5 | $1.93 | +392.23% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.03 | +2,812.62% | 1 | Dec 5, 2022 |
Kazia Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $2 → $13
Current: $8.38
Upside: +55.13%
Senseonics Holdings
Jul 8, 2025
Maintains: Buy
Price Target: $1.1 → $1.4
Current: $0.49
Upside: +188.66%
Plus Therapeutics
Jun 27, 2025
Maintains: Buy
Price Target: $5.5 → $3
Current: $0.48
Upside: +521.12%
CASI Pharmaceuticals
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.30
Upside: +207.69%
Cytosorbents
May 15, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.85
Upside: +17.65%
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $6.19
Upside: +126.17%
Dogwood Therapeutics
Apr 23, 2025
Upgrades: Buy
Price Target: $10
Current: $4.84
Upside: +106.83%
Alphatec Holdings
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $10.58
Upside: +89.04%
Monopar Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $41.18
Upside: -2.87%
Corvus Pharmaceuticals
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $4.17
Upside: +163.79%
Mar 12, 2025
Maintains: Buy
Price Target: $7.5 → $9.5
Current: $1.93
Upside: +392.23%
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $1.03
Upside: +2,812.62%